Kalender
Markeder
Råvarer
Valuta
Lagre
Obligationer
Krypto
Indikatorer
Lande
Kalender
Markeder
Valuta
Lagre
Råvarer
Obligationer
Krypto
Indtjening
Ferie
Lande
Usa
Forenede Kongerige
Euroområdet
Australien
Canada
Japan
Kina
Brasilien
Rusland
Indien
Mere Lande
Indikatorer
Rentesats
Inflation-Rate
Arbejdsløshed Rate
Bnp-Vækst
Bnp Per Capita
Betalingsbalance
Guldreserver
Statsgældsforvaltningen
Crude Oil Produktion
Benzin Priser
Kreditvurdering
Mere Indikatorer
Prognoser
Lande
Indikatorer
Valuta
Lagre
Råvarer
Obligationer
Krypto
Apps
App Store
Google Play
Twitter
Regeneron Pharmaceuticals | Salgsomkostninger Og Administration
Feedback
Selling And Administration Expenses
Lave om
Dato
AbbVie
USD 3.61B
273M
2023-12
Agios Pharmaceuticals
USD 35.3M
9.48M
2023-12
Alnylam Pharmaceuticals
USD 198.12M
1.05M
2023-12
Amgen
USD 1.76B
424M
2023-12
Astellas Pharma
JPY 179.28B
11.1B
2023-09
AstraZeneca
USD 3.91B
194M
2023-09
Biogen
USD 608.5M
179.7M
2023-12
BioMarin Pharmaceutical
USD 275.02M
51.1M
2023-12
Bluebird Bio
USD 40.7M
354K
2023-09
Bristol-Myers Squibb
USD 2.06B
126M
2023-12
Eli Lilly
USD 1.92B
120.7M
2023-12
Esperion Therapeutics
USD 33.24M
719K
2023-09
Gilead Sciences
USD 1.61B
293M
2023-12
GlaxoSmithKline
GBP 2.18B
6M
2023-09
Incyte
USD 293.86M
25.97M
2023-12
Ionis Pharmaceuticals
USD 71.01M
1.06M
2023-12
J&J
USD 5.81B
410M
2023-12
Kyowa Hakko Kirin
JPY 34.25B
3.85B
2023-09
Merck
USD 2.75B
272M
2023-12
Moderna
USD 470M
28M
2023-12
Neurocrine Biosciences
USD 204.2M
17.6M
2023-09
Opthea
USD 10.62M
6.87M
2023-06
Pfizer
USD 4.47B
1.27B
2023-12
Regeneron Pharmaceuticals
USD 737.7M
97.2M
2023-12
Roche Holding
CHF 6.51B
26M
2023-06
Sarepta Therapeutics
USD 120.89M
2.33M
2023-09
Teva Pharmaceutical Industries
USD 844M
66M
2023-09
Ultragenyx Pharmaceutical
USD 76.83M
1.92M
2023-12
United Therapeutics
USD 128.6M
1000K
2023-12
Vertex Pharmaceuticals
USD 263.8M
1.2M
2023-09
Regeneron Pharmaceuticals Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.